Explore more publications!

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on April 3, 2026

Spyre Therapeutics Announces Grants of Inducement Awards
No evento FII Miami, o futebol tornou-se um sistema de saúde — e o primeiro jogo já está em curso no México
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
VitalRIZE Claims Evaluated: The Max Vitalize Virility Enhancement Support Supplement for Men
Power Life High Impact Plant Protein Claims Evaluated: The Cleanest Vegan Protein Powder on the Market by PowerLife
ELECTE Releases AI Agent Upgrade and Advances Toward SOC 2 Compliance
Innovation at Its Core: How Top Air Filter Element Manufacturers Are Enhancing Air Filtration Performance
NicSRS Wraps Up CloudFest 2026, Showcasing SSL Automation and Code Signing Solutions
Chinese Top 3 Egg White Powder Makers in 2026: Leading the Global Protein Ingredient Industry Forward
Weight Watchers Announces Leadership Transition and Board Updates 
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
Maximus Ranked #7 on the Financial Times’ List of The Americas’ Fastest Growing Companies 2026
How Top Spunlace Nonwoven Fabric Manufacturers Are Shaping the Future of Nonwoven Textiles
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
Global Virus Network Monitors SARS-CoV-2 Variant BA.3.2 (“Cicada”), Emphasizes No Cause for Alarm
Air Diet Review: The Air-Fryer Meal Plan For Personalized Nutrition
Rhythm Pharmaceuticals Announces Changes to Board of Directors
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions